Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment
about
Vaccine development for tuberculosis: current progressImmunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during TreatmentA humanized mouse model of tuberculosisGr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infectionPharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment durationMycobacterial Cultures Contain Cell Size and Density Specific Sub-populations of Cells with Significant Differential Susceptibility to Antibiotics, Oxidative and Nitrite StressLimited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomasImmunity to intracellular Salmonella depends on surface-associated antigens.The role of B cells and humoral immunity in Mycobacterium tuberculosis infectionThe path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis.Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosisPresence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis.The association between sterilizing activity and drug distribution into tuberculosis lesions.Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection modelSterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.B cells and antibodies in the defense against Mycobacterium tuberculosis infectionPulmonary Tuberculosis in Humanized Mice Infected with HIV-1Rv1894c is a novel hypoxia-induced nitronate monooxygenase required for Mycobacterium tuberculosis virulence.Prediction of Drug Penetration in Tuberculosis LesionsEarly Secreted Antigenic Target of 6-kDa of Mycobacterium tuberculosis Stimulates IL-6 Production by Macrophages through Activation of STAT3De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.The pathology of Mycobacterium tuberculosis infection.Immunity to TB and targets for immunotherapy.Targeting dormant bacilli to fight tuberculosis.Nonclinical models for antituberculosis drug development: a landscape analysis.Metabolic activity of mature biofilms of Mycobacterium tuberculosis and other non-tuberculous mycobacteria.Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients.A new unifying theory of the pathogenesis of tuberculosis.Reversal of Mycobacterium tuberculosis phenotypic drug resistance by 2-aminoimidazole-based small molecules.The C3HeB/FeJ mouse model recapitulates the hallmark of bovine tuberculosis lung lesions following Mycobacterium bovis aerogenous infection.A rifapentine-containing inhaled triple antibiotic formulation for rapid treatment of tubercular infection.Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum.Gene Enrichment Analysis Reveals Major Regulators of Mycobacterium tuberculosis Gene Expression in Two Models of Antibiotic Tolerance.NTM drug discovery: status, gaps and the way forward.The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.Animal models of tuberculosis: Lesson learnt
P2860
Q26827737-B797128A-0545-47A1-A62F-8EC5FA76574CQ27306144-40A7931A-C64F-4CAE-ABC5-A40D5D7A724DQ27320865-5729D785-6984-4D7B-94F0-2A55A83F6F60Q28390496-DED6DF9F-1E0A-47A0-A516-1F30BB933ABDQ30377051-62CE95A7-3481-45D6-A923-E343417C2BCEQ30842403-88DF87E2-9847-47DE-9083-F5C0FDE15DF2Q33798468-D8243B7A-6E64-4DDD-958D-7367971E5F1AQ34456080-87F7ABA8-EF8C-4DA5-8EFB-EC7F7EAA7225Q35039807-6AB86C12-9F1F-4959-AB43-9E638994B05DQ35125060-99E18C65-DF01-4CAB-95A4-FA216D3F4A3EQ35164284-558C697B-B7BC-4013-8607-2A316A821AB5Q35180731-6BE0B197-3032-4CE9-BECF-C094B0EC3022Q35598474-87192EE5-F524-43B6-B741-C2233589E07EQ35687132-46E66514-66FC-4402-A467-5C5C367C8E21Q35765601-DCD0F800-B515-4E5E-A6D0-08B2F7B6EF91Q35864589-2022F3AF-7906-48CC-9E12-E139322141CDQ36018542-1AB929AD-E86C-42BD-A291-EC4E4FE18701Q36018624-438CF6F2-340C-4034-9C4E-46EF33A3078AQ36238031-92D6B400-ECE7-4641-82BC-62EDB31B85B6Q36731941-AD7AA206-4400-4387-9D76-B38BFB31AE34Q36768250-E661260F-917A-41CD-8445-556B9C8C9D45Q37265786-19710565-5621-4F81-A5BC-876CF905BAE0Q37595300-FEEEAE45-EE52-46E3-AB81-3FE3C8E64499Q37612996-56A5111F-A25A-450B-82AB-DA62E88E5C9DQ37977379-140229C6-61D1-4213-914F-3681E788F79CQ37984571-CA7DDF29-35F7-4711-AAC3-E6343F34B86EQ38173371-15A0E3E4-DA94-46E2-BFE0-28EC78AFB986Q38502294-7CC1C7A4-4D68-4F15-9178-F91B782FB910Q38611135-CBD259BB-B6D7-4ED2-9831-44E8F18637E9Q38851434-ABAAE76F-A02C-4F8A-97EC-FF567702E9D8Q39062681-8FB87888-E397-41EB-9DCC-6724508589D5Q41844019-7270BA80-06AC-4B71-A01F-592E19A804EBQ42074150-D12AE398-AB4F-43D6-830F-0F82896630A0Q45937860-824A4F48-59D0-40E7-858D-1705CC024222Q46650295-2844437A-53F9-460B-A606-25C2330591A8Q49193526-C0D901F7-1CDC-42B6-9FC4-CCB2C91B2DA5Q52579183-403A4959-5260-48AA-BFBB-01A671EC779DQ52596288-A966A9F9-D91D-4284-93E8-50AB9E722814Q55232003-ED40C74E-0B61-4272-89D3-7B42FFA7A8CCQ57096004-46ECE27E-F074-4203-B0F6-13C258C99B2A
P2860
Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Location of intra- and extrace ...... ssion and after drug treatment
@ast
Location of intra- and extrace ...... ssion and after drug treatment
@en
Location of intra- and extrace ...... ssion and after drug treatment
@nl
type
label
Location of intra- and extrace ...... ssion and after drug treatment
@ast
Location of intra- and extrace ...... ssion and after drug treatment
@en
Location of intra- and extrace ...... ssion and after drug treatment
@nl
prefLabel
Location of intra- and extrace ...... ssion and after drug treatment
@ast
Location of intra- and extrace ...... ssion and after drug treatment
@en
Location of intra- and extrace ...... ssion and after drug treatment
@nl
P2093
P2860
P1433
P1476
Location of intra- and extrace ...... ssion and after drug treatment
@en
P2093
Anne J Lenaerts
Cornelius C Ssemakulu
Donald R Hoff
Emily R Driver
Gavin J Ryan
Mary A De Groote
Randall J Basaraba
P2860
P304
P356
10.1371/JOURNAL.PONE.0017550
P407
P577
2011-03-21T00:00:00Z